期刊文献+

柱切换RP-HPLC测定血浆中那格列奈的浓度 被引量:2

Determination of Nateglinide in human plasma by RP-HPLC with column switching technique
下载PDF
导出
摘要 目的 建立测定血浆中那格列奈浓度的方法。方法 采用RP—HPLC法,LunaC18(2)分析柱(150mm×4.6mm,5μm)和大连装KromasilC18预处理柱(25mm×4.6mm,5μm),分析柱和预处理柱用流动相分别为0.025mol·L^-1磷酸-乙腈(58:42,氨水调pH6.6)和0.025mol·L^-1磷酸-乙腈(70:30,氨水调pH7.4),流速均为1.0ml·min^-1,样品血浆再加入pH2.1磷酸盐缓冲液。用二氯甲烷萃取浓集后进样,于210nm检测,以双氯酚酸作内标,按内标法定量。结果 标准曲线在0.025~16.000mg·L^-1范围内有良好的线性关系,最低定量限为0.025mg·L^-1,那格列奈和内标的保留时间分别为4.7、3.6min,分析方法的日内RSD〈6%,日间RSD〈10%,方法回收率90%~100%。结论 该法具有快速简便,灵敏准确等特点,适用于那格列奈血药浓度的测定。 OBJECTIVE To establish an RP - HPLC method with column - switching technique for the determination of Nateglinide (NG) in human plasma. METHODS Kromasil C18 pretreatment column(25 mm x 4.6 mm, 5 μm) and Luna Cs (2) analytical column ( 150 mm ×4. 6 mm, 51μm) were used. After being added pH 2. 1 phosphate buffer, the plasma sample was extracted with 3.5 ml dichloromethane. After evaporation of the organic layer, the residue was dissolved in mobile phase and injected onto the column. The mobile phase of 0. 025 mol·L^-1 phosphoric acid - acetonitrile(70 : 30, pH7.4) and phosphoric acid - acetonitrile(58 : 42, pH6. 6) were pumped at the rate of 1.0ml·min^-1 through the pretreatment and analytical column, respectively. The column - switching time was from 0. 8 min to 1.5 min. 210 nm wavelength was used. RESULTS The retention times of NG and internal standard were 4. 7 min and 3. 6 min, respectively. The standard curve was linear over the concentration range of 0. 025 to 16. 000 mg·L^-1. The lowest concentration of detection in plasma was 0. 025 mg·L^-1. The recovery of method was 90% - 100% with the intra - day RSD less than 6% and inter - day RSD less than 10%. CONCLUSION This method is simple, rapid, sensitive and accurate for determination of NG in human plasma.
出处 《华西药学杂志》 CAS CSCD 北大核心 2006年第5期456-458,共3页 West China Journal of Pharmaceutical Sciences
关键词 那格列奈 血药浓度 反相高效液相色谱法 Nateglinide RP - HPLC Plasma drug concentration
  • 相关文献

参考文献3

  • 1郁健,杜春波,杨劲.高效液相色谱法测定人血浆中那格列奈的含量[J].药物分析杂志,2004,24(2):164-167. 被引量:7
  • 2Weaver ML,Orwig BA,Rodriguez LC,et al.Pharmacokinetics and metabolism of nateglinide in humans[J].Drug Metabolism and Disposition,2001,29(4):415-421.
  • 3Qi Meiling,Wang Peng,Wang Jun,et al.A stability-indicating HPLC method for the determination of nateglinide in a new tablet formulation[J].J Chinese Pharmac Sci,2002,11(3):101-104.

二级参考文献3

  • 1Sato Y,Nishikawa M, Shinkai H. High performance liquid chromatographic method for quantitation of a new antidiabetic agent in plasma. J Liq Chromatogr, 1988,11 ( 16 ) :3425.
  • 2Ono I, Matsuda K, Kanno S. Determination of N - ( trans - 4 - isopropylcyclohexanecarbonyl) -D- phenylalanine and its metabolites in human plasma and urine by column - switching high - performance liquid chromatography with ultraviolet detection. J Chromatogr B, 1997,692:397.
  • 3Weaver ML, Orwig BA, Rodriguez LC, et al. Pharmacokinetics and metabolism of nateglinide in humans. Drug Metab Dispos, 2001,29(4) :415.

共引文献6

同被引文献2120

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部